We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-2.32%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.98B
AUM Growth
-$301M
Cap. Flow
-$222M
Cap. Flow %
-11.2%
Top 10 Hldgs %
59.53%
Holding
44
New
3
Increased
3
Reduced
36
Closed

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$40.1M
2
CSCO icon
Cisco
CSCO
+$26.8M
3
BIIB icon
Biogen
BIIB
+$25.2M
4
ORCL icon
Oracle
ORCL
+$23.4M
5
UL icon
Unilever
UL
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 22.72%
2 Communication Services 15.66%
3 Consumer Staples 14.21%
4 Healthcare 13.52%
5 Industrials 12.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.2T
$159M 8.02%
839,596
-93,044
-10% -$16.3M
DIS icon
2
Walt Disney
DIS
$178B
$150M 7.57%
1,347,733
-188,275
-12% -$19.8M
MSFT icon
3
Microsoft
MSFT
$3.66T
$132M 6.66%
313,457
-46,062
-13% -$19.6M
RTX icon
4
RTX Corp
RTX
$300B
$130M 6.58%
1,127,118
-331,988
-23% -$40.1M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.09T
$126M 6.37%
278,612
-47,936
-15% -$22.1M
UL icon
6
Unilever
UL
$133B
$126M 6.37%
1,979,332
-338,512
-15% -$22.9M
ORCL icon
7
Oracle
ORCL
$442B
$111M 5.62%
668,184
-131,995
-16% -$23.4M
MDT icon
8
Medtronic
MDT
$116B
$90.3M 4.55%
1,130,258
-225,787
-17% -$19.5M
AAPL icon
9
Apple
AAPL
$4.41T
$78.7M 3.97%
314,141
-18,059
-5% -$4.26M
JNJ icon
10
Johnson & Johnson
JNJ
$629B
$75.3M 3.8%
520,352
-12,087
-2% -$1.87M
GD icon
11
General Dynamics
GD
$107B
$61.4M 3.1%
232,952
-8,338
-3% -$2.4M
NVO
12
Novo Nordisk
NVO
$203B
$60.3M 3.04%
700,634
-7,885
-1% -$853K
V icon
13
Visa
V
$671B
$55.5M 2.8%
175,677
-8,845
-5% -$2.66M
ACN icon
14
Accenture
ACN
$110B
$54.8M 2.76%
155,676
-8,185
-5% -$2.95M
NKE icon
15
Nike
NKE
$60.1B
$49.7M 2.51%
656,900
-52,289
-7% -$4.11M
CHRW icon
16
C.H. Robinson
CHRW
$17.1B
$49.1M 2.47%
474,895
-42,011
-8% -$4.52M
SBUX icon
17
Starbucks
SBUX
$124B
$48.4M 2.44%
530,477
-18,245
-3% -$1.77M
DEO icon
18
Diageo
DEO
$52.2B
$42.4M 2.14%
333,433
-33,533
-9% -$4.27M
WMT icon
19
Walmart Inc
WMT
$923B
$42.3M 2.13%
468,318
-21,025
-4% -$1.82M
HD icon
20
Home Depot
HD
$342B
$41.2M 2.08%
105,859
-42,692
-29% -$17.4M
ASML icon
21
ASML
ASML
$695B
$37.7M 1.9%
54,351
+53,273
+4,942% +$38.3M
ADBE icon
22
Adobe
ADBE
$103B
$32.1M 1.62%
72,136
-3,357
-4% -$1.66M
PG icon
23
Procter & Gamble
PG
$335B
$27.9M 1.41%
166,693
-3,878
-2% -$660K
PEP icon
24
PepsiCo
PEP
$189B
$25.1M 1.27%
164,944
-10,439
-6% -$1.71M
LLY icon
25
Eli Lilly
LLY
$1.09T
$24.2M 1.22%
+31,307
New +$25.9M

Similar funds

Saratoga Research & Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Saratoga Research & Investment Management held 44 positions worth $1.98B, down 13% from $2.28B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Saratoga Research & Investment Management withdrew a net $222M in Q4 2024, reducing 36 holdings. Its largest reduction was RTX Corp, cutting an estimated $40.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Saratoga Research & Investment Management opened a new position in Eli Lilly worth $24.2M.

  • Saratoga Research & Investment Management's largest Q4 2024 buy was Eli Lilly: 31,307 shares worth $24.2M.
  • Saratoga Research & Investment Management added most to ASML in Q4 2024, an estimated $38.3M increase.
  • Saratoga Research & Investment Management's biggest Q4 2024 reduction was RTX Corp, cutting an estimated $40.1M.
  • Saratoga Research & Investment Management's ten largest holdings make up 60% of its $1.98B portfolio in Q4 2024.
  • Saratoga Research & Investment Management opened 3 new positions and closed 0 in Q4 2024.
  • Saratoga Research & Investment Management's portfolio value fell 13% quarter-over-quarter to $1.98B.

Based on Saratoga Research & Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.